Literature DB >> 33483476

Emerging multifaceted roles of BAP1 complexes in biological processes.

Aileen Patricia Szczepanski1, Lu Wang2.   

Abstract

Histone H2AK119 mono-ubiquitination (H2AK119Ub) is a relatively abundant histone modification, mainly catalyzed by the Polycomb Repressive Complex 1 (PRC1) to regulate Polycomb-mediated transcriptional repression of downstream target genes. Consequently, H2AK119Ub can also be dynamically reversed by the BAP1 complex, an evolutionarily conserved multiprotein complex that functions as a general transcriptional activator. In previous studies, it has been reported that the BAP1 complex consists of important biological roles in development, metabolism, and cancer. However, identifying the BAP1 complex's regulatory mechanisms remains to be elucidated due to its various complex forms and its ability to target non-histone substrates. In this review, we will summarize recent findings that have contributed to the diverse functional role of the BAP1 complex and further discuss the potential in targeting BAP1 for therapeutic use.

Entities:  

Year:  2021        PMID: 33483476      PMCID: PMC7822832          DOI: 10.1038/s41420-021-00406-2

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  79 in total

1.  Genetic profiling in acute myeloid leukemia.

Authors:  Gillian Horne; John Brewin; Timothy Chevassut
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

2.  Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.

Authors:  Johanna C Scheuermann; Andrés Gaytán de Ayala Alonso; Katarzyna Oktaba; Nga Ly-Hartig; Robert K McGinty; Sven Fraterman; Matthias Wilm; Tom W Muir; Jürg Müller
Journal:  Nature       Date:  2010-05-02       Impact factor: 49.962

3.  The Additional sex combs gene of Drosophila is required for activation and repression of homeotic loci, and interacts specifically with Polycomb and super sex combs.

Authors:  T A Milne; D A Sinclair; H W Brock
Journal:  Mol Gen Genet       Date:  1999-06

4.  Loss of the tumor suppressor BAP1 causes myeloid transformation.

Authors:  Anwesha Dey; Dhaya Seshasayee; Rajkumar Noubade; Dorothy M French; Jinfeng Liu; Mira S Chaurushiya; Donald S Kirkpatrick; Victoria C Pham; Jennie R Lill; Corey E Bakalarski; Jiansheng Wu; Lilian Phu; Paula Katavolos; Lindsay M LaFave; Omar Abdel-Wahab; Zora Modrusan; Somasekar Seshagiri; Ken Dong; Zhonghua Lin; Mercedesz Balazs; Rowena Suriben; Kim Newton; Sarah Hymowitz; Guillermo Garcia-Manero; Flavius Martin; Ross L Levine; Vishva M Dixit
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

5.  Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Authors:  Shahram Misaghi; Søren Ottosen; Anita Izrael-Tomasevic; David Arnott; Mohamed Lamkanfi; James Lee; Jinfeng Liu; Karen O'Rourke; Vishva M Dixit; Angus C Wilson
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

6.  A de novo truncating mutation in ASXL1 associated with segmental overgrowth.

Authors:  Stephanie Efthymiou; Vincenzo Salpietro; Erica Pironti; Maria Bonsignore; Valentina Ferrazzoli; Gabriella Di Rosa; Henry Houlden
Journal:  J Genet       Date:  2019-12       Impact factor: 1.166

7.  ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.

Authors:  Aileen Patricia Szczepanski; Zibo Zhao; Tori Sosnowski; Young Ah Goo; Elizabeth Thomas Bartom; Lu Wang
Journal:  Genome Med       Date:  2020-07-15       Impact factor: 11.117

8.  BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

Authors:  Lei Yu; Natee Jearawiriyapaisarn; Mary P Lee; Tomonori Hosoya; Qingqing Wu; Greggory Myers; Kim-Chew Lim; Ryo Kurita; Yukio Nakamura; Anne B Vojtek; Jean-François Rual; James Douglas Engel
Journal:  Genes Dev       Date:  2018-11-21       Impact factor: 11.361

9.  Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.

Authors:  Jiajun Zhu; Morgan A Sammons; Greg Donahue; Zhixun Dou; Masoud Vedadi; Matthäus Getlik; Dalia Barsyte-Lovejoy; Rima Al-awar; Bryson W Katona; Ali Shilatifard; Jing Huang; Xianxin Hua; Cheryl H Arrowsmith; Shelley L Berger
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

10.  Modeling Bainbridge-Ropers Syndrome in Xenopus laevis Embryos.

Authors:  Hava Lichtig; Artyom Artamonov; Hanna Polevoy; Christine D Reid; Stephanie L Bielas; Dale Frank
Journal:  Front Physiol       Date:  2020-02-18       Impact factor: 4.566

View more
  5 in total

1.  Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.

Authors:  Lu Wang; Noah Warren Birch; Zibo Zhao; Carson Meredith Nestler; Alexander Kazmer; Anthony Shilati; Alisha Blake; Patrick Alexander Ozark; Emily Jane Rendleman; Didi Zha; Caila Ann Ryan; Marc Alard Jonathan Morgan; Ali Shilatifard
Journal:  Nat Cancer       Date:  2021-05-25

2.  A cryptic K48 ubiquitin chain binding site on UCH37 is required for its role in proteasomal degradation.

Authors:  Jiale Du; Sandor Babik; Yanfeng Li; Kirandeep K Deol; Stephen J Eyles; Jasna Fejzo; Marco Tonelli; Eric Strieter
Journal:  Elife       Date:  2022-04-22       Impact factor: 8.713

3.  Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.

Authors:  Sébastien Küry; Frédéric Ebstein; Alice Mollé; Thomas Besnard; Ming-Kang Lee; Virginie Vignard; Tiphaine Hery; Mathilde Nizon; Grazia M S Mancini; Jacques C Giltay; Benjamin Cogné; Kirsty McWalter; Wallid Deb; Hagar Mor-Shaked; Hong Li; Rhonda E Schnur; Ingrid M Wentzensen; Anne-Sophie Denommé-Pichon; Cynthia Fourgeux; Frans W Verheijen; Eva Faurie; Rachel Schot; Cathy A Stevens; Daphne J Smits; Eileen Barr; Ruth Sheffer; Jonathan A Bernstein; Chandler L Stimach; Eliana Kovitch; Vandana Shashi; Kelly Schoch; Whitney Smith; Richard H van Jaarsveld; Anna C E Hurst; Kirstin Smith; Evan H Baugh; Suzanne G Bohm; Emílie Vyhnálková; Lukáš Ryba; Capucine Delnatte; Juanita Neira; Dominique Bonneau; Annick Toutain; Jill A Rosenfeld; Séverine Audebert-Bellanger; Brigitte Gilbert-Dussardier; Sylvie Odent; Frédéric Laumonnier; Seth I Berger; Ann C M Smith; Franck Bourdeaut; Marc-Henri Stern; Richard Redon; Elke Krüger; Raphaël Margueron; Stéphane Bézieau; Jeremie Poschmann; Bertrand Isidor
Journal:  Am J Hum Genet       Date:  2022-01-19       Impact factor: 11.043

Review 4.  ASXL1/2 mutations and myeloid malignancies.

Authors:  Edward A Medina; Caroline R Delma; Feng-Chun Yang
Journal:  J Hematol Oncol       Date:  2022-09-06       Impact factor: 23.168

Review 5.  Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.

Authors:  Moshe Lapidot; Srinivas Vinod Saladi; Ravi Salgia; Martin Sattler
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.